Factors Associated With Long-term Retention in Antiretroviral Therapy Among People Living With HIV: Evidence From a Tertiary Hospital in Jakarta, Indonesia
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: This study investigated factors associated with the retention of people living with human immunodeficiency virus (HIV) on antiretroviral therapy (ART) during the first 3 years of treatment.Methods: A retrospective study using electronic health records was conducted at a tertiary hospital in Jakarta, Indonesia. Adult HIV-positive patients who started ART from 2010 until 2020 were included. A binary logistic regression model was used to identify factors associated with ART retention in the first 3 years.Results: In total, 535 respondents were included in the analysis. The ART retention rates for the first, second, and third years were 83.7%, 79.1%, and 77.2%, respectively. The multivariate analysis revealed a negative association between CD4 count when starting ART and retention. Patients with CD4 counts >200 cells/mL were 0.65 times less likely to have good retention than those with CD4 counts ≤200 cells/mL. The year of starting ART was also significantly associated with retention. Patients who started ART in 2010-2013 or 2014-2016 were less likely to have good retention than those who started ART in 2017-2020, with adjusted odds ratios of 0.52 and 0.40, respectively. Patients who received efavirenz-based therapy were 1.69 times more likely to have good retention than those who received nevirapine (95% confidence interval, 1.05 to 2.72).Conclusions: Our study revealed a decline in ART retention in the third year. The CD4 count, year of enrollment, and an efavirenz-based regimen were significantly associated with retention. Patient engagement has long been a priority in HIV programs, with interventions being implemented to address this issue.
Abstract
Objectives: This study investigated factors associated with the retention of people living with human immunodeficiency virus (HIV) on antiretroviral therapy (ART) during the first 3 years of treatment.Methods: A retrospective study using electronic health records was conducted at a tertiary hospital in Jakarta, Indonesia. Adult HIV-positive patients who started ART from 2010 until 2020 were included. A binary logistic regression model was used to identify factors associated with ART retention in the first 3 years.Results: In total, 535 respondents were included in the analysis. The ART retention rates for the first, second, and third years were 83.7%, 79.1%, and 77.2%, respectively. The multivariate analysis revealed a negative association between CD4 count when starting ART and retention. Patients with CD4 counts >200 cells/mL were 0.65 times less likely to have good retention than those with CD4 counts ≤200 cells/mL. The year of starting ART was also significantly associated with retention. Patients who started ART in 2010-2013 or 2014-2016 were less likely to have good retention than those who started ART in 2017-2020, with adjusted odds ratios of 0.52 and 0.40, respectively. Patients who received efavirenz-based therapy were 1.69 times more likely to have good retention than those who received nevirapine (95% confidence interval, 1.05 to 2.72).Conclusions: Our study revealed a decline in ART retention in the third year. The CD4 count, year of enrollment, and an efavirenz-based regimen were significantly associated with retention. Patient engagement has long been a priority in HIV programs, with interventions being implemented to address this issue.
참고문헌 (23)
- "UNAIDS global AIDS update 2022"[URL]
- "The response to HIV in Asia and the Pacific — global AIDS update 2019" (2019)[URL]
- "Infodatin HIV AIDS"[URL]
- Chen M, "Social determinants of health in electronic health records and their impact on analysis and risk prediction : a systematic review", J Am Med Inform Assoc, 27(11), pp.1764~1773 (2020)[DOI]
- Adekanmbi O, "Retention in care among patients attending a large HIV clinic in Nigeria who were treated for tuberculosis", J Int Assoc Provid AIDS Care, 21, pp.23259582221124826~ (2022)[DOI]
- Shah GH, "Factors associated with retention of HIV patients on antiretroviral therapy in care : evidence from outpatient clinics in two provinces of the democratic Republic of the Congo(DRC)", Trop Med Infect Dis, 7(9), pp.229~ (2022)[DOI]
- Januraga PP, "The cascade of HIV care among key populations in Indonesia : a prospective cohort study", Lancet HIV, 5(10), pp.e560~e568 (2018)[DOI]
- implementation research in Indonesia, "Indian J Med Res", 2022, 729~741, 10.4103[DOI]
- Long L, "Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa : a rapid systematic review", J Int AIDS Soc, 23(11), pp.e25640~ (2020)[DOI]
- Koole O, "Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia", Trop Med Int Health, 19(12), pp.1397~1410 (2014)[DOI]
- Ibiloye O, "Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria : a retrospective cohort study", PLoS One, 16(11), pp.e0260557~ (2021)[DOI]
- Yehia BR, "Barriers and facilitators to patient retention in HIV care", BMC Infect Dis, 15, pp.246~ (2015)[DOI]
- Rooks-Peck CR, "Mental health and retention in HIV care : a systematic review and meta-analysis", Health Psychol, 37(6), pp.574~585 (2018)[DOI]
- Lee S, "Predictors of poor retention in care of HIV-infected patients receiving antiretroviral therapy in Korea : five-year hospital-based retrospective cohort study", J Korean Med Sci, 31(3), pp.376~381 (2016)[DOI]
- Holtzman CW, "Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen’s Behavioral Model", AIDS Care, 27(7), pp.817~828 (2015)[DOI]
- Rosen S, "Patient retention in antiretroviral therapy programs in sub-Saharan Africa : a systematic review", PLoS Med, 4(10), pp.e298~ (2007)[DOI]
- Vuylsteke B, "Retention and risk factors for loss to follow-up of female and male sex workers on antiretroviral treatment in Ivory Coast : a retrospective cohort analysis", J Acquir Immune Defic Syndr, 68(Suppl 2), pp.S99~S106 (2015)[DOI]
- Tegegne AS, "Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study", BMC Infect Dis, 18(1), pp.83~ (2018)[DOI]
- Atuhaire L, "A retrospective cross sectional study assessing factors associated with retention and non-viral suppression among HIV positive FSWs receiving antiretroviral therapy from primary health care facilities in Kampala, Uganda", BMC Infect Dis, 22(1), pp.642~ (2022)[DOI]
- Ajeh RA, "Determinants of retention in HIV antiretroviral treatment(ART)in the Cameroon International epidemiology Database to Evaluate AIDS(IeDEA)study clinics : the context of the HIV treat all strategy in Cameroon", Pan Afr Med J, 40, pp.129~ (2021)[DOI]
- Damulak PP, "Interventions to improve adherence to antiretroviral therapy(ART)in sub-Saharan Africa : an updated systematic review", Int J Environ Res Public Health, 18(5), pp.2477~ (2021)[DOI]
- McDonagh EM, "PharmGKB summary : efavirenz pathway, pharmacokinetics", Pharmacogenet Genomics, 25(7), pp.363~376 (2015)[DOI]
- Chendi BH, "Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon : a longitudinal cohort study", BMC Infect Dis, 19(1), pp.194~ (2019)[DOI]